Insider Trading & Ownership of Sandeep Laumas

Location
Raleigh, MA
Summary
The estimated net worth of Sandeep Laumas is at least $319,912 dollars as of 12 Jan 2026. Sandeep Laumas is the 10%+ Owner of Hillstream BioPharma Inc. and owns shares of Canton Strategic Holdings, Inc. (CNTN) stock worth about $319.9K.
Signature
/s/ Richard Steinhart, Attorney-in-Fact for Sandeep Laumas
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Sandeep Laumas and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Quick Takeaways

  • Sandeep Laumas has 4 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $319,912.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Hillstream BioPharma Inc. ($319,912).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Sandeep Laumas

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CNTN Hillstream BioPharma Inc. 10%+ Owner $319,912 11 Jan 2022
TIL Instil Bio, Inc. CFO and CBO $0 -$701,667 -100% 10 Sep 2025
BTAI BioXcel Therapeutics, Inc. Director 09 Jan 2026
UNCY Unicycive Therapeutics, Inc. Director 28 Jul 2025

Insider Transactions Reported by Sandeep Laumas:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .